Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).

B, You; G, Salles; E, Bachy; O, Casasnovas; H, Tilly; V, Ribrag; C, Sebban; E, Hénin; J, Guitton; M, Tod

doi:10.1007/s00280-015-2866-9

Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).

NobleIDNI0P10W79R68S23

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EC5DFADE.svg?ark=w1%2F20260526%2FEC5DFADE&value=id)](https://nobleid.org/work/w1/20260526/EC5DFADE)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).

NobleIDNI0P10W79R68S23

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EC5DFADE.svg?ark=w1%2F20260526%2FEC5DFADE&value=id)](https://nobleid.org/work/w1/20260526/EC5DFADE)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work